Stockreport

Cost of new drug development is key concern for life science as focus shifts to repurposing

Willis Towers Watson Public Limited Company - Ordinary Shares  (WTW) 
Last willis towers watson public limited company - ordinary shares earnings: 2/26 04:05 pm Check Earnings Report
US:NYSE Investor Relations: weightwatchersinternational.com
PDF LONDON, June 27, 2024 (GLOBE NEWSWIRE) -- 63% of life science companies believe the high cost of new drug development is among the emerging themes that will have the g [Read more]